Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Body mass index can determine the healing of reflux esophagitis with Los Angeles Grades C and D by esomeprazole.

The American journal of gastroenterology - 1 Sept 2008

Sheu Bor-Shyang, Chang Wei-Lun, Cheng Hsui-Chi, Kao Ai-Wen, Lu Cheng-Chan

Abstract excerpt

AIMS: This study assessed the endoscopic healing rates of reflux esophagitis with Los Angeles grades C and D (RE-CD) using a 6-month esomeprazole and the demographic factors or genotypes of S-mephenytoin 4'-hydroxylase (CYP2C19) that correlated with the healing of RE-CD. METHODS: One hundred thirteen patients with RE-CD received esomeprazole 40 mg daily for 6 months and completed serial follow-ups regarding...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Analysis of Variance
Share to Anti-Ulcer Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aryl Hydrocarbon Hydroxylases

Share to Body Mass Index

Share to Chi-Square Distribution

Share to Cytochrome P-450 CYP2C9

Share to Dose-Response Relationship, Drug

Share to Severity of Illness Index

Source

Identifiers

PMID: 18702650
DOI: 10.1111/j.1572-0241.2008.01979.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Body mass index can determine the healing of reflux esophagitis with Los Angeles Grades C and D by esomeprazole.PMID 18702650Read ↗

CYP2C19 genotypes determine the efficacy of on-demand therapy of pantoprazole for reflux esophagitis as Los-Angeles grades C and D.Semantic proximity Read ↗

Epidemiology of the complications of gastroesophageal reflux disease.Semantic proximity Read ↗

Genetic variations in medical versus surgical patients with GERD: beyond PPIs and fundoplications.Semantic proximity Read ↗

Prevalence of CYP2C19 phenotypes in patients undergoing a hiatal hernia repair.Semantic proximity Read ↗

Association between the body mass index, waist circumference, and body fat percentage with erosive esophagitis in adults with obesity after sleeve gastrectomySemantic proximity Read ↗

Role of cytochrome P450 2C19 genetic polymorphisms in the therapeutic efficacy of omeprazole in Iranian patients with erosive reflux esophagitis.Semantic proximity Read ↗

Comparison of Clinical Features of Acute Esophageal Mucosal Lesions and Those of Reflux Esophagitis Los Angeles Classification Grade DSemantic proximity Read ↗

Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19: evidence from clinical and pharmacokinetic data.Semantic proximity Read ↗

Ilaprazole for the treatment of duodenal ulcer: a randomized, double-blind and controlled phase III trial.Semantic proximity Read ↗

CYP2C19 genotype is associated with symptomatic recurrence of GERD during maintenance therapy with low-dose lansoprazole.Semantic proximity Read ↗

Prevalence of CYP2C19 polymorphisms in medically and surgically managed patients with GERD.Semantic proximity Read ↗

Personalized anti-reflux surgery: connecting GERD phenotypes in 690 patients to outcomes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.